Michael Barclay discusses Columbia Dividend Income fund strategy and stock picks
Updated
Updated · Barron's · May 7
Michael Barclay discusses Columbia Dividend Income fund strategy and stock picks
3 articles · Updated · Barron's · May 7
Barclay said the $47bn fund has returned 12.9% annually over a decade, holds 81 stocks, yields 1.6%, and is top 15% in its Morningstar category.
He said the strategy favours dividend growers with strong cash flow and balance sheets, with biggest bets in financials, tech and healthcare, including JPMorgan, Analog Devices, Johnson & Johnson and AstraZeneca.
Barclay said the fund targets total return, with 60% to 70% from capital gains and 30% to 40% from dividends, while recently adding Altria as a tariff-resilient income play.
With rates 'higher for longer,' how will the fund's big bank holdings continue their 8%+ dividend growth?
As AI reshapes markets, is a dividend-focused strategy enough to capture the next wave of tech growth?
Can Altria’s pivot to smokeless products truly fuel future dividend growth as its core business declines?